News & Perspective

Dec 21, 2006

Dec 21, 2006

HHS seeks advice on allocating pandemic vaccine

(CIDRAP News) – The Department of Health and Human Services is seeking help from the public in figuring out how to allocate scarce supplies of influenza vaccine in the event of a flu pandemic.

In a Dec 14 Federal Register notice, HHS invited the public to submit comments on which groups should have priority for receiving pre-pandemic and pandemic vaccines and on related issues. The deadline for commenting is Jan 18, 2007.

Nov 20, 2006

Nov 20, 2006

HHS awards 3 contracts for more H5N1 vaccine

(CIDRAP News) – The US government today announced the awarding of three contacts to buy enough additional H5N1 avian influenza vaccine to immunize almost 2.7 million people, at a cost of $199.45 million.

Nov 17, 2006

Nov 17, 2006

HHS: Most H5N1 vaccine on hand is still potent

(CIDRAP News) – A Department of Health and Human Services official said today that loss of potency is affecting less than 20% of H5N1 avian influenza vaccine doses in the national stockpile, not a majority of doses as reported here yesterday.

Bill Hall, an HHS spokesman in Washington, DC, said the agency has acquired a total of about 7.5 million doses of H5N1 vaccine to date, and about 200,000 of those have been used for research.

Oct 17, 2006

Oct 17, 2006

Baxter says cell-based H5N1 vaccine shows potential in trial

(CIDRAP News) – Low doses of a cell-based avian flu vaccine triggered a good immune response to the H5N1 avian influenza virus, according to preliminary results of a clinical trial by Baxter International of Deerfield, Ill., maker of the vaccine.

Oct 02, 2006

Oct 02, 2006

FDA issues guide to ease production of cell-based vaccines

(CIDRAP News) – In a major push to modernize and speed the production of vaccines for pandemic influenza and other emerging threats, the US Food and Drug Administration (FDA) last week issued new guidance on how to safely and effectively develop new cell-based vaccines.

Aug 08, 2006

Aug 08, 2006

Professional groups call on White House to elevate role of pandemic flu vaccines

(CIDRAP News) – Two national groups of infectious disease experts urged the White House to make the development of vaccines the most important element in the nation's pandemic influenza plan.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Jun 02, 2006

Jun 02, 2006

Flu vaccine makers get HHS funds to prepare for pandemic

Jun 20, 2007 (CIDRAP News) – Federal health officials last week announced the awarding of contracts totaling $132.5 million to help two vaccine producers get ready to start churning out vaccines in the event of a flu pandemic.

May 04, 2006

May 04, 2006

US awards $1 billion for cell-based flu vaccines

(CIDRAP News) – In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»